A recent American Diabetes Association (ADA) update advises that all adults with type 2 diabetes or prediabetes be screened for nonalcoholic fatty liver disease (NAFLD).
This update emphasizes the importance of early detection of NAFLD in people with diabetes as well as appropriate management modalities. Early detection allows for timely treatment, reducing the chance of developing other serious complications.
Liver disease affects up to 70% of people with type 2 diabetes. NAFLD, which includes nonalcoholic steatohepatitis (NASH), is the most common form of liver disease in people with diabetes. NAFLD can lead to cirrhosis and liver cancer and is associated with an increased risk of cardiovascular disease and death.
Read more about the update here.